AxoGen Profit Margin 2006-2020 | AXGN
Current and historical gross margin, operating margin and net profit margin for AxoGen (AXGN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. AxoGen net profit margin as of June 30, 2020 is -28.04%.
|AxoGen Annual Profit Margins
|AxoGen Quarterly Profit Margins
||Medical Instruments Manufacturing
AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States.